1. Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents
   Mohammad Amin Manavi et al, 2024, Journal of Chemotherapy CrossRef
2. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38
   Vaskor Bala et al, 2013, Journal of Controlled Release CrossRef
3. Enabling Oral SN38-Based Chemotherapy with a Combined Lipophilic Prodrug and Self-Microemulsifying Drug Delivery System
   Vaskor Bala et al, 2016, Molecular Pharmaceutics CrossRef
4. Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era
   Shuaiqi Wang et al, 2024, Biomedicines CrossRef
5. Application of a Combination of a Knowledge-Based Algorithm and 2-Stage Screening to Hypothesis-Free Genomic Data on Irinotecan-Treated Patients for Identification of a Candidate Single Nucleotide Polymorphism Related to an Adverse Effect
   Hiro Takahashi et al, 2014, PLoS ONE CrossRef
6. Preventive Effects of a Chinese Herbal Formula, Shengjiang Xiexin Decoction, on Irinotecan-Induced Delayed-Onset Diarrhea in Rats
   Chao Deng et al, 2017, Evidence-Based Complementary and Alternative Medicine CrossRef
7. Irinotecan and Δ9-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers
   Ana Lucić Vrdoljak et al, 2018, Molecules CrossRef
8. Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice
   Silvia H. S. P. Pedroso et al, 2015, Microbiology CrossRef
9. GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy
   Congcong Lin et al, 2020, Acta Pharmaceutica Sinica B CrossRef
10. Targeted therapy for breast cancer: An overview of drug classes and outcomes
    Aaron T. Jacobs et al, 2022, Biochemical Pharmacology CrossRef
11. High Doses of Δ9-Tetrahydrocannabinol Might Impair Irinotecan Chemotherapy: A Review of Potentially Harmful Interactions
    Nevenka Kopjar et al, 2020, Clinical Drug Investigation CrossRef
12. A mechanism-based understanding of altered drug pharmacokinetics by gut microbiota
    Aneela Gulnaz et al, 2023, Journal of Pharmaceutical Investigation CrossRef